The initiative, led by Dr. Constanza Maximiano and developed with Drs. María Torrente and Alicia Frisuelos, proposes combining physical exercise, personalized nutrition, and mindfulness to improve the quality of life for patients with advanced ovarian cancer during oncological treatment.
The project, supported by a grant from the GEICO Foundation, aims to enhance the quality of life for women with advanced ovarian cancer undergoing treatment with PARP inhibitors (iPARPs), which are targeted therapies that eliminate tumor cells. INCOREPARP builds upon the CORE program, previously developed at the same hospital for breast cancer patients, which demonstrated benefits in reducing fatigue and improving quality of life.
Ovarian cancer is one of the most frequent gynecological tumors and the leading cause of death from this type of cancer, often diagnosed in advanced stages. Standard treatments, while essential, can cause side effects such as fatigue or psychological distress.
The comprehensive program will be conducted over 12 weeks at the hospital, monitoring 60 patients. It will include aerobic and resistance training, a personalized Mediterranean diet, and an 8-week mindfulness program. It also incorporates a digital health platform for remote monitoring of symptoms and treatment adherence.




